FI970247A0 - Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin - Google Patents

Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin

Info

Publication number
FI970247A0
FI970247A0 FI970247A FI970247A FI970247A0 FI 970247 A0 FI970247 A0 FI 970247A0 FI 970247 A FI970247 A FI 970247A FI 970247 A FI970247 A FI 970247A FI 970247 A0 FI970247 A0 FI 970247A0
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
binding protein
compositions containing
tnf binding
chimeric tnf
Prior art date
Application number
FI970247A
Other languages
English (en)
Swedish (sv)
Other versions
FI970247A (fi
Inventor
Robert Fredrich Geoffrey Booth
Werner Lesslauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI970247A0 publication Critical patent/FI970247A0/fi
Publication of FI970247A publication Critical patent/FI970247A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI970247A 1994-07-22 1997-01-21 Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin FI970247A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111455 1994-07-22
PCT/EP1995/002788 WO1996003141A1 (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a chimaeric tnf binding protein

Publications (2)

Publication Number Publication Date
FI970247A0 true FI970247A0 (fi) 1997-01-21
FI970247A FI970247A (fi) 1997-01-21

Family

ID=8216138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970247A FI970247A (fi) 1994-07-22 1997-01-21 Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin

Country Status (11)

Country Link
EP (1) EP0772449A1 (fi)
JP (1) JPH09508140A (fi)
AU (1) AU3111995A (fi)
BR (1) BR9508419A (fi)
CA (1) CA2195665A1 (fi)
CZ (1) CZ283219B6 (fi)
FI (1) FI970247A (fi)
HU (1) HUT76666A (fi)
NO (1) NO970264L (fi)
PL (1) PL318501A1 (fi)
WO (1) WO1996003141A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
CN1233189A (zh) * 1996-05-08 1999-10-27 弗·哈夫曼-拉罗切有限公司 用TNFR-Ig治疗哮喘
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP0948543A1 (en) * 1996-12-12 1999-10-13 Genentech, Inc. Hvem polypeptides and uses thereof
ATE250784T1 (de) 1998-11-27 2003-10-15 Synaptics Uk Ltd Positionssensor
HUP0303246A2 (hu) 2001-02-23 2003-12-29 Immunex Corporation Aktív fehérjék fokozott kinyerése
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
PT1471974E (pt) 2002-02-06 2007-10-12 Ares Trading Sa Factor de necrose tumural combinado com interferão em doenças desmielinizantes
JP5553963B2 (ja) 2004-10-22 2014-07-23 アムジエン・インコーポレーテツド 組換え抗体をリフォールディングする方法
CA2958578A1 (en) 2014-08-21 2016-02-25 The General Hospital Corporation Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
DK0417563T3 (da) * 1989-09-12 2000-11-06 Hoffmann La Roche TNF-bindende proteiner
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin
KR100232688B1 (ko) * 1992-09-15 1999-12-01 스코트 쥐. 홀퀴스트 종양 괴사 인자 길항제를 함유하는 tnf-의존성 염증 치료용 제약 조성물
CA2147180A1 (en) * 1992-10-15 1994-04-28 Gokhan S. Hotamisligil Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function

Also Published As

Publication number Publication date
AU3111995A (en) 1996-02-22
PL318501A1 (en) 1997-06-23
HUT76666A (en) 1997-10-28
CZ283219B6 (cs) 1998-02-18
WO1996003141A1 (en) 1996-02-08
NO970264L (no) 1997-03-24
CA2195665A1 (en) 1996-02-08
BR9508419A (pt) 1997-11-18
CZ19397A3 (en) 1997-06-11
NO970264D0 (no) 1997-01-21
EP0772449A1 (en) 1997-05-14
FI970247A (fi) 1997-01-21
JPH09508140A (ja) 1997-08-19

Similar Documents

Publication Publication Date Title
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
FI970247A0 (fi) Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin
ZA947122B (en) Drug binding protein.
IS1903B (is) 2-methýl-thíenó-bensódíasepín, samsetning til inntöku
FI965202A0 (fi) Farmaseuttiset takriinikoostumukset
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
ID22891A (id) Komposisi farmasi untuk kombinasi piperidinoalkanol-dekongestan
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
HU9503199D0 (en) Pharmaceutical basic compositions
DE69508180D1 (de) Heissschmelzende Tintenstrahlzusammensetzung
EP0796321A4 (en) PROTEINS BINDING TO PROTEIN E2
DE69705017T2 (de) Medikamente bindendes Protein
ZA9811572B (en) Novel anti-diabetic composition.
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI962738A (fi) Farmaseuttiset koostumukset
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina
LTIP2039A (en) Binding composition, containing anhydrite
IT1285093B1 (it) Composizione farmaceutica per malattie cardiovascolari e renali.
IL110319A0 (en) Pharmaceutical compositions containing protein
SE9402924D0 (sv) Novel pharmaceutical composition
GB9409736D0 (en) Biocidal protein compositions
HU9802107D0 (en) Pharmaceutical composition containing plazma proteins
TR199500776A2 (tr) Farmasötik bilesimler.
SI0724588T1 (en) Drug binding protein
ZA941531B (en) Improved pharmaceutical composition